Clinicians with obligations to patients and to organizations often assess patients in law enforcement for both therapeutic and nontherapeutic purposes.
AMA J Ethics. 2022;24(2):E111-119. doi:
10.1001/amajethics.2022.111.
Charles E. Binkley, MD, Michael S. Politz, MA, and Brian P. Green, PhD
If the safe-and-effective standard for judging devices’ potential as therapy or enhancement is inadequate, one might wonder whether BCI regulation should be overseen by the FDA.
AMA J Ethics. 2021;23(9):E745-749. doi:
10.1001/amajethics.2021.745.
Mark Gilbert, PhD, Leanne Picketts, MEd, Anna MacLeod, PhD, and Wendy A. Stewart, MD, MMEd, PhD
This study offers an arts-based tool set capable of being delivered within the familiar medical education setting and established structure of the OSCE.
AMA J Ethics. 2022;24(7):E556-562. doi:
10.1001/amajethics.2022.556.
Sophia Miao, MD and Wendy A. Stewart, MD, MMEd, PhD
This pilot study used phenomenology combined with quantitative measures of self-esteem and self-efficacy to explore influences of storytelling through lyrical and musical composition on youth self-concept.
AMA J Ethics. 2022;24(7):E576-583. doi:
10.1001/amajethics.2022.576.
Miranda B. Olson, MSc, Stacey Springs, PhD, and Jay Baruch, MD
Responsible arts in health research requires interrogating what counts as evidence, especially when the insistence on rigor risks oversimplifying and diminishing what’s ineffable about the arts.
AMA J Ethics. 2022;24(7):E617-621. doi:
10.1001/amajethics.2022.617.